Question · asked by 1 review

Pneumococcal conjugate vaccine vs control vaccine: CRM197‐PCV7in high‐risk infants

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Pneumococcal conjugate vaccine vs control vaccine
CRM197‐PCV7in high‐risk infants · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)
Pneumococcal conjugate vaccines for preventing acute otitis media in children (2020) · Cochrane Headline outcomes only
no estimate extracted1 study · 944 participantsLow
Pneumococcal conjugate vaccine vs control vaccine
CRM197‐PCV7in high‐risk infants · infants (predominantly < 6 months of age) and older children (aged 1 to 7 years)
Pneumococcal conjugate vaccines for preventing acute otitis media in children (2019) · Cochrane Headline outcomes onlyearlier version CD001480.PUB5, superseded
no estimate extracted1 study · 944 participantsModerate

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Pneumococcal conjugate vaccines for preventing acute otitis media in children
2020 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.